Promoter methylation gain of one such promising candidate gene, ankyrin repeat and SOCS-box containing protein 2 (ASB2), within the TET2-target site is investigated in an independent series of primary prostate tumors. The gene discussed is ASB2; the disease is prostate neoplasm.